We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+1.09%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+879.75%
AUM
$50.8B
AUM Growth
-$294M
(-0.58%)
Cap. Flow
-$328M
Cap. Flow
% of AUM
-0.65%
Top 10 Holdings %
Top 10 Hldgs %
22.21%
Holding
1,137
New
127
Increased
273
Reduced
442
Closed
122
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$255M |
| 2 |
Textron
TXT
|
+$206M |
| 3 |
AstraZeneca
AZN
|
+$164M |
| 4 |
ExxonMobil
XOM
|
+$124M |
| 5 |
Moderna
MRNA
|
+$121M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$962M |
| 2 |
WORK
Slack Technologies, Inc.
WORK
|
+$204M |
| 3 |
Devon Energy
DVN
|
+$201M |
| 4 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$170M |
| 5 |
Carrier Global
CARR
|
+$155M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.3% |
| 2 | Healthcare | 15.98% |
| 3 | Financials | 14.49% |
| 4 | Consumer Discretionary | 11.52% |
| 5 | Communication Services | 8.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
526
NVR
NVR
$16.9B
| $17M | 0.03% |
3,556
-100
| -3% | -$508K |
|
|
LHC
527
DELISTED
Leo Holdings Corp. II
LHC
| $17M | 0.03% |
1,750,000
| – | – |
|
|
NSTC
528
DELISTED
Northern Star Investment Corp. III
NSTC
| $17M | 0.03% |
1,750,000
| – | – |
|
|
K
529
DELISTED
Kellanova
K
| $17M | 0.03% |
283,862
-4,153
| -1% | -$249K |
|
|
INZY
530
DELISTED
Inozyme Pharma
INZY
| $17M | 0.03% |
1,467,828
+179,156
| +14% | +$2.79M |
|
531
Quanta Services
PWR
$100B
| $16.9M | 0.03% |
148,691
-2,100
| -1% | -$211K |
|
532
Stanley Black & Decker
SWK
$15.3B
| $16.9M | 0.03% |
96,479
-7,500
| -7% | -$1.46M |
|
533
Werewolf Therapeutics
HOWL
$19.6M
| $16.9M | 0.03% |
985,448
-15,149
| -2% | -$259K |
|
534
MarketAxess Holdings
MKTX
$5.72B
| $16.7M | 0.03% |
39,750
-600
| -1% | -$275K |
|
|
SCOB
535
DELISTED
ScION Tech Growth II Class A Ordinary Shares
SCOB
| $16.6M | 0.03% |
1,703,841
| – | – |
|
536
Adient
ADNT
$1.48B
| $16.6M | 0.03% |
400,000
+300,000
| +300% | +$12M |
|
537
Omnicom Group
OMC
$22.6B
| $16.6M | 0.03% |
228,750
-5,300
| -2% | -$394K |
|
|
CHAA
538
DELISTED
Catcha Investment Corp
CHAA
| $16.6M | 0.03% |
1,700,000
| – | – |
|
|
SCOA
539
DELISTED
ScION Tech Growth I Class A Ordinary Shares
SCOA
| $16.5M | 0.03% |
1,700,000
| – | – |
|
|
NUAN
540
DELISTED
Nuance Communications, Inc.
NUAN
| $16.5M | 0.03% |
300,000
| – | – |
|
|
TWKS
541
DELISTED
Thoughtworks Holding, Inc. Common Stock
TWKS
| $16.5M | 0.03% |
+575,000
| New | +$17M |
|
|
VTIQ
542
DELISTED
VectoIQ Acquisition Corp. II Class A Common Stock
VTIQ
| $16.5M | 0.03% |
1,700,000
| – | – |
|
|
DAY
543
DELISTED
Dayforce
DAY
| $16.5M | 0.03% |
+146,200
| New | +$15.4M |
|
544
DTE Energy
DTE
$29.1B
| $16.4M | 0.03% |
146,922
+28,247
| +24% | +$3.31M |
|
545
AES
AES
$10.5B
| $16.3M | 0.03% |
713,212
-866,421
| -55% | -$21M |
|
546
SentinelOne
S
$7.12B
| $16.1M | 0.03% |
300,000
-50,000
| -14% | -$2.74M |
|
547
Velocity Financial
VEL
$715M
| $16M | 0.03% |
1,214,133
-77,272
| -6% | -$985K |
|
|
DRE
548
DELISTED
Duke Realty Corp.
DRE
| $15.9M | 0.03% |
333,102
+85,629
| +35% | +$4.32M |
|
549
Avery Dennison
AVY
$13.2B
| $15.7M | 0.03% |
76,000
+13,700
| +22% | +$2.94M |
|
|
ABMD
550
DELISTED
Abiomed Inc
ABMD
| $15.7M | 0.03% |
48,343
+29,300
| +154% | +$9.93M |
|
Similar funds
Adage Capital Partners's Q3 2021 Portfolio in Review
As of Q3 2021, Adage Capital Partners held 1,137 positions worth $50.8B, down 0.58% from $51.1B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Adage Capital Partners's Q3 2021 filing shows 127 new, 273 increased, 442 reduced and 122 closed positions. Its largest new stake was Pfizer: 5,759,101 shares worth $248M. The largest sale was Alexion Pharmaceuticals, an estimated $962M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- Adage Capital Partners's largest Q3 2021 buy was Pfizer: 5,759,101 shares worth $248M.
- Adage Capital Partners added most to Textron in Q3 2021, an estimated $206M increase.
- Adage Capital Partners's biggest Q3 2021 reduction was Devon Energy, cutting an estimated $201M.
- Adage Capital Partners fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $962M.
- Adage Capital Partners's ten largest holdings make up 22% of its $50.8B portfolio in Q3 2021.
- Adage Capital Partners opened 127 new positions and closed 122 in Q3 2021.
- Adage Capital Partners's portfolio value fell 0.58% quarter-over-quarter to $50.8B.
Based on Adage Capital Partners's 13F filing for Q3 2021, filed 15 Nov 2021.